Beroni Group signs agreement with Genscript Biotech to conduct further study to develop nanobody-based medical solution for Covid-19
Beroni Group signs agreement with Genscript Biotech to conduct further study to develop nanobody-based medical solution for Covid-19. (Credit: fernando zhiminaicela from Pixabay)